Susquehanna International Group
NKGN

Susquehanna International Group’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Susquehanna International Group’s Portfolio NKGN Stock Details NKGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,906
Closed -$32K – 13445
2024
Q1 		$32K Buy
+16,906
New +$32.5K ﹤0.01% 11697
2023
Q1 		– Sell
-24,593
Closed -$245K – 13675
2022
Q4 		$245K Buy
24,593
+10,756
+78% +$106K ﹤0.01% 9617
2022
Q3 		$135K Buy
+13,837
New +$135K ﹤0.01% 11386

Other funds holding NKGN

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Susquehanna International Group's NKGN Position: Q2 2024 in Review

Susquehanna International Group sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q2 2024, closing a stake of 16,906 shares — an estimated $32K sold.

Susquehanna International Group first reported a position in NKGN in Q3 2022 and held it in 3 quarters. The position peaked at $245K in Q4 2022. 17 funds tracked by Wall St. Rank hold NKGN as of Q2 2024.

  • Susquehanna International Group reported no remaining NKGen Biotech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 16,906 NKGen Biotech, Inc. Common Stock shares in Q2 2024, an estimated $32K.
  • Susquehanna International Group first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Susquehanna International Group's NKGen Biotech, Inc. Common Stock position peaked at $245K in Q4 2022.
  • 17 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.